Home > Insider Trading > Filing (0001415889-24-002062)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1991792	Cg Oncology Inc.	CGON	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1487815	Xiangmin Cui	Ugland House, Po Box 309 Grand Cayman E9 KY1-1104	No	No	Yes	No
1834150	Decheng Capital Global Life Sciences Fund Iv, L.p.	Ugland House, Po Box 309 Grand Cayman E9 KY1-1104	No	No	No	No
1843384	Decheng Capital Management Iv (Cayman), Llc	Ugland House, Po Box 309 Grand Cayman E9 KY1-1104	No	No	Yes	No
1949026	Decheng Capital Global Healthcare Fund (Master), Lp	Ugland House, Po Box 309 Grand Cayman E9 KY1-1104	No	No	Yes	No
1949027	Decheng Capital Global Healthcare Gp, Llc	Ugland House, Po Box 309 Grand Cayman E9 KY1-1104	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-01-29	3,628,198	$0.00	4,558,812	No	4	C	Direct
Common Stock	Acquisiton	2024-01-29	400,000	$19.00	400,000	No	4	P	Indirect	By Decheng Capital Global Healthcare Fund (Master), LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Indirect	By Decheng Capital Global Healthcare Fund (Master), LP

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series C Preferred Stock	Disposition	2024-01-29	8,644,891	$0.00	906,648	$0.00
Common Stock	Series E Preferred Stock	Disposition	2024-01-29	21,547,685	$0.00	2,259,851	$0.00
Common Stock	Series F Preferred Stock	Disposition	2024-01-29	4,402,320	$0.00	461,701	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct

Footnotes

Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.
These securities are held directly by Decheng Capital Global Life Sciences Fund IV, L.P. ("Fund IV"). Decheng Capital Management IV (Cayman), LLC ("GP IV") is the general partner of Fund IV. Xiangmin Cui is the manager of GP IV. Each of Fund IV, GP IV and Dr. Cui may be deemed to beneficially own the securities held by Fund IV. Each of GP IV and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein.
These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP ("Healthcare"). Decheng Capital Global Healthcare GP, LLC ("Healthcare GP") is the general partner of Healthcare. Xiangmin Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein.